Modulation of Cathepsin-D and pS2 protein levels in human breast cancer cell lines

Tumor Biology

Volumn 17, Issue 5, 1996, Pages 290-298

  Cappelletti, V ^a   Fioravanti, L ^a   Inoue, Akira ^b   Di Fronzo, G ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

Author keywords

Breast cancer cell lines; Cathepsin D; Growth factor; Hormone dependence; pS2

Indexed keywords

CATHEPSIN D; EPIDERMAL GROWTH FACTOR; ESTRADIOL; PROGESTERONE RECEPTOR; PROTEIN PS2; SOMATOMEDIN C;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0029791932     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000217991     Document Type: Article

References (22)

1. Fockens JA, van Putten WL, Portengcn H, dc Koning HY, Thirion S, Alexieva-Figusch JA, Klijn JG: Prognostic value of pS2 and cathep-sin D in 710 human primary breast tumors: Multivariate analysis, J Clin Oncol 1993;11:899-908.
2. Granata G, Coradini D, Cappelletti V, Di Fronzo G: Prognostic relevance of cathepsin-D versus estrogen receptors in node-negative breast cancer, Eur J Cancer 1991:27: 970-972.
3. Gion M, Mione R, Pappagallo GL, Gatti C, Nascimben O, Bari M, Leon AE, Vinante O, Bruscagnin G: pS2 is an independent factor of good prognosis in primary breast cancer, BrJ Cancer 1993;68:93-96.
4. Tandon AK, Clark GM, Chamncss GC, Chirgwin JM, McGuire WL: Calhepsin D and prognosis in breast cancer, N Engl J Med 1990:322: 297-302.
5. Westley BR, May FEB: Oestrogen regulates cathcpsin D mRNA levels in oestrogen responsive human breast cancer cell lines, Nucleic Acids Res 1987;9:3773-3786.
6. Cavailles V, Augerau P, Rochefort H: Cathcpsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells, Proc Natl Acad Sci USA 1993:90: 203-207.
7. Cavailles V, Garcia M, Rochefort H: Regulation of calhepsin-D and pS2 gene expression by growth factors in MCF-7 human breast cancer cells, Mol Endocrinol 1989:3:552-558.
8. Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua SAW, Hil-senbeck SH, Chamness GC, Osborne CK: Cathcpsin D by Western blotting and immunohislochemis-try: Failure to confirm correlations with prognosis in node-negative breast cancer, J Clin Oncol 1994:12: 467-474.
9. Thomssen C, Janicke F, Pach L, Blaser J, Oppelt F, Prechtl A, Shmitt M, Tschcsche H, Graeff II: Prognostic value of tumor associated proteases in breast cancer, Breast Cancer RcsTreat 1993:27:140.
10. Johnson MD, Torri JA, Lippman ME, Dickson RB: The role of cathcpsin D in the invasiveness of human breast cancer cells, Cancer Res 1993:53:873-877.
11. Cappelletti V, Coradini D, Scan-ziani E, Benini E, Silvestrini R, Di Fronzo G: Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer, Eur J Cancer 1992:28A; 1315-1318.
12. Brown AMC, Jeltsch JM, Roberts M, Chambon P: Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci USA 1984:81:6344-6348.
13. Nunez AM, Berry M, imler JL, Chambon P: The 5-flanking region of the pS2 gene contains a complex enhancer region responsive to oes-trogens, epidermal growth factor, a tumor promoter, the c-Ha-ra, r oncoprotein and the c-juti protein, EMBOJ 1989;8:823-829.
14. Van der Burg B, Ruttcman G, Blan-kenstein M, Van de Laal S, Van Zoelen E: Mitogenic stimulation of human breast cancer cells in a growth factor defined medium: Synergistic action of insulin and estrogen, J Cell Physiol 1988:134:101-108.
15. Burton K: A study of the conditions and mechanism of diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid, Bio-chemJ 1956:62:315-323.
16. Cappelletti V, Brivio M, Miodini P, Coradini D, Di Fronzo G: Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors, Tumor Biol 1988:9:200-211.
17. Cappelletti V, Ruedl C, Miodini P, Fioravanti L, Coradini D, Di Fronzo G, Silvestrini R: Paracrine interaction in co-culture of hormone-dependent and independent breast cancer cells, Breast Cancer Res Treat 1993:26:275-281.
18. Cappelletti V, Palriarca C, Granata G, Cattorctti G, Coradini D, Di Fronzo G, Horwitz K: Progesterone receptor determination in human breast tumors by immunocytochem-ical and biochemical techniques, Breast Cancer Res Treat 1989:14: 217-225.
19. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protcin-dyc binding, Anal Biochem 1976:72: 248-259.
20. Early Breast Cancer Trialist Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immunotherapy, Lancet 1992;339:1-15.
21. Ravdin PM, Green S, Melink DT, McGuire WL, Fabian C, Pugh RP, Carter RD, Rivkin SE, Borst JR, Belt RJ, Metch B, Osborne CK: Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treatment with tamoxifen: Results of a prospective Southwest Oncology Group study, J Clin Oncol 1992:10:1284-1291.
22. Hoosein NM, Thint L, Jorgensen KH, Brattain MG: Growth stimulatory effects of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells, FEBS Lett 1989: 247:303-306.